I contacted them in regards to the question of what was in the $4.9m "Other Costs" figure in the 4C. The reply was that they were unable to comment on anything beyond what is publicly announced, which is essentially the right answer. We'll just have to wait for the FY results to find out. I'm sure this $4.9m is nothing to worry about, but rather is there to help the business grow.
However, what they should be doing is foreseeing the big questions people will ask, and providing that detail in the announcement.
- Forums
- ASX - By Stock
- GSS
- Q4 Instrumentation sales growth
Q4 Instrumentation sales growth, page-7
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GSS (ASX) to my watchlist
(20min delay)
|
|||||
Last
71.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $161.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19136 | 68.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
70.5¢ | 3221 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19136 | 0.685 |
2 | 11387 | 0.675 |
2 | 8261 | 0.670 |
2 | 43713 | 0.665 |
1 | 7800 | 0.645 |
Price($) | Vol. | No. |
---|---|---|
0.705 | 21 | 1 |
0.710 | 3200 | 1 |
0.715 | 4145 | 2 |
0.720 | 37500 | 1 |
0.730 | 10000 | 1 |
Last trade - 10.41am 13/11/2024 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online